BSD Medical Corp. (BSDM)
-NasdaqGM 1.28 
0.01(0.70%) 2:46PM EDT - Nasdaq Real Time Price
| Prev Close: | 1.29 |
|---|
| Open: | 1.30 |
|---|
| Bid: | 1.28 x 56400 |
|---|
| Ask: | 1.29 x 300 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.46 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.26 - 1.32 |
|---|
| 52wk Range: | 0.76 - 2.41 |
|---|
| Volume: | 98,044 |
|---|
| Avg Vol (3m): | 294,919 |
|---|
| Market Cap: | 38.11M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.28 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BSD Medical Delivers BSD-2000 Hyperthermia System to Cancer Treatment Centers of America® in ArizonaBusiness Wire(Wed, Jun 5)
- BSD MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online(Wed, May 29)
- BSD Medical sell MicroThermX Microwave Ablation System to NJ University Hospitaltheflyonthewall.com(Wed, May 22)
- University Hospital in New Jersey Purchases MicroThermX® Microwave Ablation System from BSD MedicalBusiness Wire(Wed, May 22)
- Terumo Europe NV Begins Commercial Distribution of BSD Medical Corporation’s MicroThermX® Microwave Ablation System at European Conference on Interventional OncologyBusiness Wire(Thu, May 16)
- BSD Medical Announces BSD-2000 Marketing Approval Submission to Taiwan Food and Drug Administration by Linden BioscienceBusiness Wire(Mon, May 13)
- BSD Medical Announces Purchase Order for Hyperthermia Systems in TaiwanBusiness Wire(Wed, May 8)
- BSD Medical Closes Previously Announced $5 Million Registered Direct Offering of Common Stock and WarrantsBusiness Wire(Mon, Apr 15)
- BSD Medical News To Create A Sparkat Seeking Alpha(Thu, Apr 11)
- BSD MEDICAL CORP FinancialsEDGAR Online Financials(Wed, Apr 10)
- BSD Medical Announces Registered Direct Offering of Common Stock and Warrants in Aggregate Amount of $5 MillionBusiness Wire(Tue, Apr 9)
- BSD MEDICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements aEDGAR Online(Tue, Apr 9)
- BSD MEDICAL CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Mon, Apr 8)
- BSD Medical Announces Exclusive Multi-Million Dollar Distribution Agreement with Terumo Europe NV for MicroThermX® Microwave Cancer Ablation SystemBusiness Wire(Mon, Apr 8)
- BSD MEDICAL CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, Apr 5)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 14.65 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Aug-13)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
BSD Medical Corporation develops, manufactures, markets, and services systems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy.
View More